• norsk
    • English
  • English 
    • norsk
    • English
  • Login
View Item 
  •   Home
  • Faculty of Medicine
  • Department of Clinical Medicine
  • Department of Clinical Medicine
  • View Item
  •   Home
  • Faculty of Medicine
  • Department of Clinical Medicine
  • Department of Clinical Medicine
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Iron therapy in inflammatory bowel disease : effects on oxidative stress and disease activity

Erichsen, Kari
Doctoral thesis
Thumbnail
View/Open
Main Thesis (998.7Kb)
Reprinted from Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease by Erichsen K, Ulvik RJ, Nysaeter G, Johansen J, Ostborg J, Berstad A, Berge RK, Hausken T, from Scand J Gastroenterol, www.tandf.no/gastro, 2005, 40, 1058-1065, by permission of Taylor & Francis AS (95.64Kb)
Reprinted from Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease by Erichsen K, Hausken T, Ulvik RJ, Svardal A, Berstad A, Berge RK, from Scand J Gastroenterol, www.tandf.no/gastro, 2003, 38, 543-548, by permission of Taylor & Francis AS (156.4Kb)
Errata.pdf (13.00Kb)
This is an electronic version of an article published in Aliment Pharmacol Ther: ERICHSEN, K., ULVIK, R. J., GRIMSTAD, T., BERSTAD, A., BERGE, R. K. & HAUSKEN, T. (2005) Effects of ferrous sulphate and non-ionic iron–polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 22 (9), 831-838. doi: 10.1111/j.1365-2036.2005.02652.x, as published in the print edition of Aliment Pharmacol Ther, is available on the Blackwell Synergy online delivery service, accessible via the journal's website at http://www.blackwellpublishing.com/journal.asp?ref=0269-2813&site=1 or www.blackwell-synergy.com (92.30Kb)
Erichsen K, Milde AM, Arslan G, Helgeland L, Gudbrandsen OA, Ulvik RJ, Berge RK, Hausken T, Berstad A. Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis. Inflamm Bowel Dis 2005;11:744-748 Reprinted with permission from Lippincott Williams & Wilkins. (726.0Kb)
URI
https://hdl.handle.net/1956/1069
Date
2005-12-09
Metadata
Show full item record
Collections
  • Department of Clinical Medicine [1000]
Description
This thesis is based on the following papers, referred to in the text by their roman numerals: I Erichsen K, Hausken T, Ulvik RJ, Svardal A, Berstad A, Berge RK. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol 2003;38:543-548. - II Erichsen K, Milde AM, Arslan G, Helgeland L, Gudbrandsen OA, Ulvik RJ, Berge RK, Hausken T, Berstad A. Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis. Inflamm Bowel Dis 2005;11:744-748. - III Erichsen K, Ulvik RJ, Nysaeter G, Johansen J, Ostborg J, Berstad A, Berge RK, Hausken T. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol 2005;40:1058-1065. - IV Erichsen K, Ulvik RJ, Grimstad T, Berge RK, Berstad A, Hausken T. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005;22:831-838.
Publisher
The University of Bergen

Contact Us | Send Feedback

Privacy policy
DSpace software copyright © 2002-2019  DuraSpace

Service from  Unit
 

 

Browse

ArchiveCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDocument TypesJournalsThis CollectionBy Issue DateAuthorsTitlesSubjectsDocument TypesJournals

My Account

Login

Statistics

View Usage Statistics

Contact Us | Send Feedback

Privacy policy
DSpace software copyright © 2002-2019  DuraSpace

Service from  Unit